Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Prolapse 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Metrorrhagia 1Fallopian Tube Neoplasms 1Endometriosis 1Endometrial Neoplasms 1

Interventions

pembrolizumab 14Paclitaxel 13Carboplatin 12Bevacizumab 7Specimen Handling 6Cisplatin 6olaparib 5Taxes 5Fulvestrant 5Nivolumab 4Megestrol Acetate 4Magnetic Resonance Spectroscopy 4Biopsy 4palbociclib 3durvalumab 3Oxaliplatin 3Leucovorin 3Letrozole 3Immunoglobulin G 3Fluorouracil 3Doxorubicin 3Docetaxel 3Disulfides 3trastuzumab deruxtecan 2ribociclib 2pertuzumab 2lenvatinib 2ipatasertib 2dostarlimab 2capivasertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Sutures × 30 days × Clear all
NCT06024109 2026-06-02

BARHYSTER

Aesculap AG

Recruiting
132 enrolled
Gynecologic

Uterine Cervical Neoplasms, Endometriosis, Fallopian Tube Neoplasms, Metrorrhagia, Ovarian Neoplasms, Uterine Neoplasms, Uterine Prolapse, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡